Homepage - CRTOnline

COVID-19 Outbreak Effects Seen in Cath Labs

COVID-19 Outbreak Effects Seen in Cath Labs

SCAI Cancels 2020 Scientific Sessions

SCAI Cancels 2020 Scientific Sessions

TVT Registry Confirms Safety of TAVR in Bicuspid Patients

TVT Registry Confirms Safety of TAVR in Bicuspid Patients https://www.crtonline.org/news-detail/tvt-registry-confirms-safety-of-tavr-in-bicuspid-p

No Increased Mortality with Paclitaxel DCBs in Coronaries

No Increased Mortality with Paclitaxel DCBs in Coronaries https://www.crtonline.org/news-detail/no-increased-mortality-with-paclitaxel-dcbs-in-cor

Patient Satisfaction Scores: Think Hotel, Not Hospital

Patient Satisfaction Scores: Think Hotel, Not Hospital https://www.crtonline.org/news-detail/patient-satisfaction-scores-think-hotel-not-hospit

Trending Now More »
Study: Renal Denervation Lowers Blood Pressure Without Medication

Mar 29, 2020 by
Charan Yerasi, crtonline.org

Catheter-based renal denervation is effective in reducing blood pressure in the absence of antihypertensive medications, according to late-breaking trial results presented Sunday at the American College of Cardiology Scientific Sessions 2020 virtual conference.

Rivaroxaban Tops Enoxaparin in Preventing VTE Events After Lower Limb Surgery

Mar 29, 2020 by
Charan Yerasi, crtonline.org

Rivaroxaban was shown to be more effective than enoxaparin in preventing major venous thromboembolic events after nonmajor orthopedic surgery of the lower limbs, according to late-breaking trial results presented Sunday at the American College of Cardiology Scientific Sessions 2020 virtual conference.

Pre-Hospital Sodium Nitrite Does Not Improve Survival in Out-of-Hospital Cardiac Arrest, Study Shows

Mar 29, 2020 by
Brian C. Case, CRTonline.org

The use of sodium nitrite during active resuscitation did not significantly improve survival to hospital admission or to discharge among patients who suffered out-of-hospital cardiac arrest, according to late-breaking trial results presented Sunday at the American College of Cardiology Scientific Sessions 2020 virtual conference.

Rivaroxaban Benefits PAD Patients, With or Without Clopidogrel, Substudy Shows

Mar 29, 2020 by
Charan Yerasi, crtonline.org

A substudy from the VOYAGER PAD trial shows that low-dose rivaroxaban is safe and effective in patients with peripheral arterial disease (PAD) undergoing revascularization, irrespective of clopidogrel use, according to late-breaking trial results presented Sunday at the American College of Cardiology (ACC) Scientific Sessions 2020 virtual conference.

Vein of Marshall Ethanol Infusion Plus Ablation Shows Potential Benefit in Persistent AFib

Mar 29, 2020 by
Nauman Khalid and Jason Wermers, CRTonline.org

Infusing ethanol into the vein of Marshall (VOM), in addition to catheter ablation of persistent atrial fibrillation (AF) reduces the recurrence of AF or atrial tachycardia (AT), reduces AF burden and may reduce the need for repeat procedures, according to study results presented Sunday at the American College of Cardiology Scientific Sessions 2020 virtual conference.

Real-World LAAO Registry Study Shows Better Results Than Trials

Mar 29, 2020 by
Charan Yerasi, CRTonline.org

In-hospital adverse events occurred at lower rates after left atrial appendage occlusion in a registry than were shown in two previous randomized trials, according to late-breaking study results presented Sunday at the American College of Cardiology Scientific Sessions 2020 virtual conference.

TAVR with Self-Expanding Prosthesis Safe, Effective In Low-Risk Patients with Bicuspid Aortic Valves

Mar 29, 2020 by
Brian Forrestal, CRTonline.org

Transcatheter aortic valve replacement (TAVR) using a self-expanding prosthesis is safe in low-risk patients with bicuspid aortic stenosis, according to late-breaking trial results presented Sunday at the American College of Cardiology Scientific Sessions 2020 virtual conference.

Oral Anticoagulation Alone Lowers Bleeding Risk After TAVR in AFib Patients

Mar 29, 2020 by
Chava Chezar-Azerrad and Jason Wermers, CRTonline.org

Patients with atrial fibrillation on oral anticoagulation (OAC) therapy who underwent transcatheter aortic valve replacement (TAVR) and continued treatment with OAC alone had a lower rate of serious bleeding at 1-year follow-up than patients who received OAC plus clopidogrel for 3 months after TAVR, according to late-breaking trial results presented Sunday at the American College of Cardiology Scientific Sessions 2020 virtual conference.

PARTNER 3: TAVR with Balloon-Expandable Valve Holds on to Advantage Over SAVR at 2 Years

Mar 29, 2020 by
Jason Wermers and Jaffar M. Khan, CRTonline.org

Patients at low surgical risk for mortality who underwent transcatheter aortic valve replacement (TAVR) with a balloon-expandable transcatheter heart valve continued to show significantly better outcomes at 2 years than those who underwent surgical aortic valve replacement (SAVR), but the differences between the two groups began to narrow from year 1 to year 2, according to late-breaking trial results presented Sunday at the American College of Cardiology (ACC) Scientific Sessions 2020 virtual conference.

TAVR, SAVR Show Comparable 1-Year Mortality Results in UK TAVI Trial

Mar 29, 2020 by
Jason Wermers and Jaffar M. Khan, CRTonline.org

Transcatheter aortic valve replacement (TAVR) was shown to be non-inferior to surgical aortic valve replacement (SAVR) in terms of mortality in patients age 70 and older deemed to be at increased surgical mortality risk, according to late-breaking trial results presented Sunday at the American College of Cardiology Scientific Sessions 2020 virtual conference.

Randomized Clinical Trial of Prehospital Sodium Nitrite in Out-of Hospital Cardiac Arrest Patients

ACC 2020 Late-Breaking Trials

Catheter-based Renal Denervation in the Absence of Antihypertensive Medications: Primary Results from the SPYRAL HTN-OFF MED Pivotal Trial

Mar 23, 2020 by Michael Böhm, MD

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with PAD undergoing Revascularization with and without Clopidogrel

Mar 29, 2020 by William R. Hiatt

Rivaroxaban versus Enoxaparin in Non-Major Orthopedic Surgery

Mar 29, 2020 by Rosencher Nadia

Apixaban for treatment of venous thromboembolism associated with cancer

Mar 29, 2020 by Giancarlo Agnelli

Vein Of Marshall Ethanol Infusion For Persistent Atrial Fibrillation: The Venus Trial

Mar 29, 2020 by Miguel Valderrábano

NCDR Left Atrial Appendage Occlusion (LAAO) Registry: Review Of The First 3 Years

Mar 29, 2020 by James V. Freeman, MD, MPH, MS
In The News See More

COVID-19 Outbreak Effects Seen in Cath Labs

by
Jason Wermers, CRTonline.org

3 Studies Highlight Potential for Coronary Obstruction After TAVR

by
Jason Wermers, CRTonline.org

SCAI Cancels 2020 Scientific Sessions

by
Jason Wermers, CRTonline.org

Joint Statement from ACC Interventional Council and SCAI: COVID 19 and the Cardiac Cath Lab

by
Rebecca Torguson, CRTonline.org

No Increased Mortality with Paclitaxel DCBs in Coronaries

by
Rick McGuire, CRTonline.org

TVT Registry Confirms Safety of TAVR in Bicuspid Patients

by
Rick McGuire, CRTonline.org

Patient Satisfaction Scores: Think Hotel, Not Hospital

by
Rick McGuire, CRTonline.org

Women, AMI, and Missed Diagnoses – All in the Symptoms?

by
Rick McGuire, CRTonline.org

14-Year Trends in PCI and CABG: Substantial Decrease in Both, Big Changes in Patients Treated

by
Rick McGuire, CRTonline.org

CRT 2020 - Thomas Zeller, Md

Latest Videos See All Interviews »

CRT 2020 - Werner Mohl, Md,Phd

Mar 10, 2020

CRT 2020 - Michael Reardon, Md

Mar 10, 2020

CRT 2020 - David Cohen

Mar 10, 2020

CRT 2020 - Mirvat Alasnag Fscai, Facp

Mar 10, 2020

CRT 2020 - Richard Shlofmitz, Md

Mar 10, 2020

CRT 2020 - Steven Yakubov, Md, Facc, Mscai 2

Mar 10, 2020

Journal Watch More »
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic

Mar 23, 2020 by
Driggin E. et al. by JACC DOI: 10.1016/j.jacc.2020.03.031

Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic. JACC STATE-OF-THE-ART REVIEW

Sex differences in left ventricular remodelling, myocardial fibrosis and mortality after aortic valve replacement

Nov 14, 2019 by
Heart 2019; 105:1818-24

Sex differences in left ventricular remodelling, myocardial fibrosis and mortality after aortic valve replacement

Intravascular Lithotripsy in Calcified Coronary Lesions. A Prospective, Observational, Multicenter Registry.

Nov 14, 2019 by
A Aksoy, et al.; Circ Cardiovasc Interv 2019; 12:e008154

Intravascular Lithotripsy in Calcified Coronary Lesions. A Prospective, Observational, Multicenter Registry.

Impact of Insulin-Treated and Noninsulin-Treated Diabetes Mellitus in All-Comer Patients Undergoing Percutaneous Coronary Interventions With Polymer-Free Biolimus-Eluting Stent (from the RUDI-FREE Reg

Nov 14, 2019 by
M Pepe, et al.; AJC 2019; 124:1518-27

Impact of Insulin-Treated and Noninsulin-Treated Diabetes Mellitus in All-Comer Patients Undergoing Percutaneous Coronary Interventions With Polymer-Free Biolimus-Eluting Stent (from the RUDI-FREE Registry).

Cardiovascular Marketplace More »
Transcatheter Mitral Valve Repair Coverage Decision Deadline Passes

Feb 19, 2020 by
CRTonline.org

Transcatheter Mitral Valve Repair Coverage Decision Deadline Passes

Tendyne Transcatheter Mitral Valve Gets CE Mark in Europe

Jan 30, 2020 by
CRTonline.org

Tendyne Transcatheter Mitral Valve Gets CE Mark in Europe

JenaValve Transcatheter Aortic Valve Replacement (TAVR) System Designated by FDA as Breakthrough Device

Jan 09, 2020
JenaValve Transcatheter Aortic Valve Replacement (TAVR) System Designated by FDA as Breakthrough Device

Vascepa Gets Coveted Event-Prevention Label

Dec 13, 2019 by
John Gever, Managing Editor, MedPage Today

Vascepa Gets Coveted Event-Prevention Label

Novartis to buy The Medicines Company for $9.7 Billion

Nov 25, 2019 by
CRTonline.org

Novartis to buy The Medicines Company for $9.7 Billion

CRT POLL

Do you feel safe in your hospital if a patient presented to the cath lab with possible or confirmed COVID-19 and needs a catheterization?

Yes

No

14%
Yes

86%
No

Show Results

1 2 3 4
1-5 of 16 results

Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience Database for Patient- and Circuit-Related Adverse Events Involving Extracorporeal Membrane Oxygenation

Mar 24, 2020 by
Nauman Khalid, Hasan Javed, Sarah Aftab Ahmad, J. James Edelman, Evan Shlofmitz, Yuefeng Chen, Anees Musallam, Toby Rogers, Hayder Hashim, Nelson L. Bernardo and Ron Waksman

Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience Database for Patient- and Circuit-Related Adverse Events Involving Extracorporeal Membrane Oxygenation

Are We Optimizing the Use of Dual Antiplatelet Therapy in Patients Hospitalized with Acute Myocardial Infarction?

Mar 24, 2020 by
Essa Hariri, Darleen Lessard, Joel Gore, Jeffrey Rade and Robert Goldberg

Are We Optimizing the Use of Dual Antiplatelet Therapy in Patients Hospitalized with Acute Myocardial Infarction?

Balloon-expandable transcatheter aortic valve replacement outcomes by procedure location: Catheterization laboratory versus operating room

Mar 24, 2020 by
Tom C. Nguyen, Patricia Keegan, Stephanie Nguyen, Pranav Loyalka, Tsuyoshi Kaneko, Pinak B. Shah, Kendra J. Grubb and Vasilis C. Babaliaros

Balloon-expandable transcatheter aortic valve replacement outcomes by procedure location: Catheterization laboratory versus operating room

Clinical Outcomes of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Stent Versus Standard Drug-Eluting Coronary Stents: A Meta-Analysis

Mar 24, 2020 by
Paul Ndunda, Mohinder R. Vindhyal, Tabitha Muutu and Zaher Fanari

Clinical Outcomes of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Stent Versus Standard Drug-Eluting Coronary Stents: A Meta-Analysis

Editorial: Misclassification of Type 2 Myocardial Infarction: Implications for Value-Based Programs and Quality Metrics

Mar 24, 2020 by
Jason H. Wasfy and Sean P. Murphy

Editorial: Misclassification of Type 2 Myocardial Infarction: Implications for Value-Based Programs and Quality Metrics

1 2 3 4
1-5 of 16 results

Early Experience With Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement in the United States

Video Presentations All Presentations »

Long-Term Outcomes of Anticoagulation for Bioprosthetic Valve Thrombosis

Mar 12, 2020

TAVR Coiling Cases

Mar 05, 2020

Two rare complications of myocardial infarction: a case report

Mar 04, 2020

Axillary Artery Occlusion after TAVR

Mar 04, 2020

The Chaperone Technique

Jan 10, 2020

Duration of DAPT After PCI With DES

Dec 13, 2019

CRTonline on Facebook

CRT Meeting

CRTonline on Twitter

Tweets by @CRT_meeting

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

* Required
* First Name:
* Last Name:
Member ID:
* Phone Number:
* Email:
* Enter code:

* Message:

COVID-19 Outbreak Effects Seen in Cath Labs

SCAI Cancels 2020 Scientific Sessions

TVT Registry Confirms Safety of TAVR in Bicuspid Patients

TVT Registry Confirms Safety of TAVR in Bicuspid Patients https://www.crtonline.org/news-detail/tvt-registry-confirms-safety-of-tavr-in-bicuspid-p

No Increased Mortality with Paclitaxel DCBs in Coronaries

No Increased Mortality with Paclitaxel DCBs in Coronaries https://www.crtonline.org/news-detail/no-increased-mortality-with-paclitaxel-dcbs-in-cor

Patient Satisfaction Scores: Think Hotel, Not Hospital

Patient Satisfaction Scores: Think Hotel, Not Hospital https://www.crtonline.org/news-detail/patient-satisfaction-scores-think-hotel-not-hospit

Trending Now More »

ACC 2020 Late-Breaking Trials

In The News See More

Latest Videos See All Interviews »

Journal Watch More »

Cardiovascular Marketplace More »

CRT POLL

Video Presentations All Presentations »

CRTonline on Facebook

CRTonline on Twitter

Explore the Site

Stay Connected

Thank you